
15 Jul 2024
FY24 slightly ahead – all eyes on NPD progress
FY24 results are slightly ahead at the Adj EBITDA and Cash levels, a very creditable achievement in the face of substantial FX headwinds and ongoing macro pressures in China. The new product development programme remains on track to deliver the first commercial launch in 2025. We make no material change to estimates at this stage and continue to see asymmetric returns potential given the undervalued core business and transformational upside potential from the pipeline. ECO is a Best Idea for 202 ....

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY24 slightly ahead – all eyes on NPD progress
Eco Animal Health Group PLC (EAH:LON) | 76.5 0 0.0% | Mkt Cap: 51.8m
- Published:
15 Jul 2024 -
Author:
Chris Glasper -
Pages:
3 -
FY24 results are slightly ahead at the Adj EBITDA and Cash levels, a very creditable achievement in the face of substantial FX headwinds and ongoing macro pressures in China. The new product development programme remains on track to deliver the first commercial launch in 2025. We make no material change to estimates at this stage and continue to see asymmetric returns potential given the undervalued core business and transformational upside potential from the pipeline. ECO is a Best Idea for 202 ....